U.S. flag

An official website of the United States government

NM_006269.2(RP1):c.2473_2474delinsTA (p.Ile825Tyr) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 3, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002589764.4

Allele description [Variation Report for NM_006269.2(RP1):c.2473_2474delinsTA (p.Ile825Tyr)]

NM_006269.2(RP1):c.2473_2474delinsTA (p.Ile825Tyr)

Gene:
RP1:RP1 axonemal microtubule associated [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
8q12.1
Genomic location:
Preferred name:
NM_006269.2(RP1):c.2473_2474delinsTA (p.Ile825Tyr)
HGVS:
  • NC_000008.11:g.54626355_54626356delinsTA
  • NG_009840.2:g.15289_15290delinsTA
  • NG_009840.3:g.72172_72173delinsTA
  • NM_001375654.1:c.787+4067_787+4068delinsTA
  • NM_006269.2:c.2473_2474delinsTAMANE SELECT
  • NP_006260.1:p.Ile825Tyr
  • NC_000008.10:g.55538915_55538916delinsTA
Protein change:
I825Y
Molecular consequence:
  • NM_001375654.1:c.787+4067_787+4068delinsTA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_006269.2:c.2473_2474delinsTA - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

  • LOC127825128 [Homo sapiens]
    LOC127825128 [Homo sapiens]
    Gene ID:127825128
    Gene
  • Iron-Dextran Complex
    Iron-Dextran Complex
    A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is use...<br/>
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002940820Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jul 3, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002940820.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces isoleucine, which is neutral and non-polar, with tyrosine, which is neutral and polar, at codon 825 of the RP1 protein (p.Ile825Tyr). This variant is present in population databases (no rsID available, gnomAD 0.002%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1911297). This variant has not been reported in the literature in individuals affected with RP1-related conditions.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024